ArticleFrontiers in cellular and infection microbiology2026
Childhood sepsis burden: pathogens/antimicrobial-resistant bacteria, 1990-2021 and 2050 forecasts.
Article in Frontiers in cellular and infection microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: To assess the global burden and trends of childhood sepsis, and to evaluate whether clarifying these aspects can provide a basis for formulating targeted prevention and treatment strategies for the condition. Methods: Using the Global Burden of Disease (GBD) 2021 database, we analyzed sepsis in 0-14-year-olds, covering 62 pathogens (21 drug-resistant), 84 "pathogen-drug" combinations, 12 infection syndromes, and indicators (deaths, disability-adjusted life years [DALYs], age-standardized rates). Antimicrobial resistance (AMR) was defined by two counterfactual scenarios; an autoregressive integrated moving average (ARIMA) model forecast AMR-related sepsis to 2050. Results: From 1990 to 2021, global sepsis-related deaths among children declined from 6.43 million to 2.24 million, and DALYs dropped from 578 million to 203 million. The estimated annual percentage change (EAPC) in age-standardized mortality rate (ASMR) and DALY rate (ASDR) was -3.35 and -3.33, respectively. AMR-related sepsis burden also decreased, with notable declines in both AMR-associated and AMR-attributable deaths and DALYs. In 2021, the highest burden remained in Sub-Saharan Africa, while the lowest was in High-income regions. Leading pathogens causing child sepsis deaths included Streptococcus pneumoniae, Klebsiella pneumoniae, Escherichia coli, Staphylococcus aureus, and Pseudomonas aeruginosa. Bloodstream infections, lower respiratory infections, and diarrhea were the most common infection syndromes leading to sepsis-related deaths. Conclusion: Global childhood sepsis burden dropped, but high-burden regions (e.g., Sub-Saharan Africa, South Asia) need focus. Future efforts should optimize healthcare, strengthen AMR control, promote vaccination, and improve sanitation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.